The Mechanism of Simvastatin-Mediated M1 Macrophage Polarization Contributing to Osteogenesis and Angiogenesis
Open Access
- 12 June 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1454
Abstract
Background: The immune response is essential for bone regeneration, and macrophages in the immune microenvironment contribute to bone metabolism and angiogenesis. Emerging evidence demonstrates that simvastatin is a promising candidate for bone repair and promotes bone formation both in vitro and in vivo. However, the effect of simvastatin on macrophages and the following outcomes are still unclear. Objectives: This study aimed to investigate the potential immunomodulatory effect of simvastatin on M1 macrophages and its subsequent impact on osteogenesis and angiogenesis. Methods: Cell viability was assessed by CCK-8. Osteogenic and angiogenic markers were evaluated by RT-qPCR, Western blotting, and immunofluorescence. M1 macrophage phenotype was analyzed by flow cytometry. Osteogenesis was examined by histological staining, and angiogenic capacity was assessed using functional assays. Results: The present study found that simvastatin decreased M1 macrophage markers (CD86) and stimulated M1 macrophages to express high levels of pro-regenerative cytokines (BMP-2 and VEGF). In addition, simvastatin promoted osteogenic differentiation in MC3T3-E1 cells and angiogenic gene expression in HUVECs. Importantly, simvastatin enhanced the osteogenic capacity of MC3T3-E1 and the angiogenic potential of HUVECs by inhibiting M1 macrophage polarization in vitro. Conclusions: We demonstrated that simvastatin could confer favorable bone immunomodulatory properties and influence the crosstalk behavior between immune cells and osteoblasts and vascular endothelial cells to promote bone healing.Keywords
Funding Information
- National Natural Science Foundation of China (62271104, LJ212410161097, LJ212410161055)
- Basic scientific research projects of colleges and universities in Liaoning Province (62271104, LJ212410161097, LJ212410161055)
This publication has 56 references indexed in Scilit:
- Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer TherapeuticsPharmaceutical Research, 2025
- Nanomaterial-Based Repurposing of Macrophage Metabolism and Its ApplicationsNano-Micro Letters, 2024
- Effect of simvastatin topical use on alveolar bone after tooth extraction: a scoping reviewClinical Oral Investigations, 2024
- Multifunctional hydrogel enhances bone regeneration through sustained release of Stromal Cell-Derived Factor-1α and exosomesBioactive Materials, 2023
- Spontaneous immunomodulation and regulation of angiogenesis and osteogenesis by Sr/Cu-borosilicate glass (BSG) bone cement to repair critical bone defectsBioactive Materials, 2023
- Regulation of Macrophage Polarization Through Periodic Photo‐Thermal Treatment to Facilitate OsteogenesisSmall, 2022
- Bone Marrow MicrovasculatureComprehensive Physiology, 2020
- Mesenchymal stem cell-macrophage crosstalk and bone healingBiomaterials, 2019
- Simvastatin Promotes Osteogenic Differentiation of Mouse Embryonic Stem Cells Via Canonical Wnt/β-Catenin SignalingMolecules and Cells, 2011
- An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extractionAnalytical Biochemistry, 2004